Submitted:
30 April 2024
Posted:
01 May 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Study Area
2.3. Target Population
2.4. Sample Size
2.5. Sampling Techniques
2.6. Data Collection
2.7. Data Management and Analysis
3. Results
3.1. Respondents/Participants Sociodemographic Characteristics
3.2. Challenges with TB Screening
3.3. Existing Gaps in the Current TB Contact Investigations
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix B
| Osun State | ||||
| S/N | LGA | FACILITY | FGD (TBP; TBC, CVs) | KII (DOTS officers, TBLS, STBLM, WDC) |
| 1 | Iwo | Feesu PHC | 3 | 3 |
| 2 | Ede South | State Hospital Ede | 3 | 3 |
| 3 | Ife Central | Enuwa PHC | 3 | 2 |
| 4 | Osogbo | State Hospital, Asubiaro | 3 | 3 |
| IHVN Staff | 1 | |||
| Total | 12 | 12+ 1 (STBLPM) | ||
| Oyo State | ||||
| 1. | Ibadan North | \PHC Sabo | 3 | 3 |
| 2. | Oyo East | State Hospital, Oyo | 3 | 3 |
| 3. | Ogbomoso South | PHC Igboyi | 3 | 3 |
| 4 | Iseyin | General Hospital Iseyin | 3 | 3 |
| IHVN Staff | 2 | |||
| Total | 12 | 13 + 1 (STBLPM) | ||
| Sociodemographic variables | No | % |
| Age* | ||
| 15-34 | 49 | 32.7 |
| 35-54 | 70 | 46.7 |
| 55-74 | 27 | 18.0 |
| 75 and above | 4 | 2.7 |
| Sex | ||
| Male | 86 | 57.3 |
| Female | 64 | 42.7 |
| Marital status | ||
| Single | 43 | 28.7 |
| Married | 98 | 65.3 |
| Separated | 3 | 2.0 |
| Divorced | 2 | 1.3 |
| Widow/widower | 4 | 2.7 |
| Religion | ||
| Islam | 85 | 56.7 |
| Christianity | 62 | 41.3 |
| Traditional | 3 | 2.0 |
| Ethnicity | ||
| Yoruba | 145 | 96.7 |
| Igbo | 3 | 2.0 |
| Others | 2 | 1.3 |
| Level of education | ||
| None | 12 | 8.0 |
| Primary | 34 | 22.7 |
| Secondary | 59 | 39.3 |
| OND/NCE | 13 | 8.7 |
| HND/First Degree | 26 | 17.3 |
| Postgraduate degree | 6 | 4.0 |
| Occupation | ||
| Civil or public servant | 29 | 19.3 |
| Trader | 37 | 24.7 |
| Farmer or fisherman | 8 | 5.3 |
| Artisan | 26 | 17.3 |
| Unemployed | 12 | 8.0 |
| Others | 38 | 25.3 |
| Respondent classification | ||
| TB patients | 47 | 31.3 |
| Government Staff | 18 | 12.0 |
| TB contacts | 39 | 26.0 |
| Community volunteers | 34 | 22.7 |
| IHVN Staff | 3 | 2.0 |
References
- World Health Organization (WHO). (2021). Global tuberculosis report 2021. Geneva: World Health Organization.
- KNCV Nigeria (2023). TB in Nigeria: A major issue with TB in Nigeria is the low TB case finding for both adults and children. Retrieved from https://kncvnigeria.org/nigeria-is-among-the-14-high-burden-countries-for-tb/.
- Yuen, C.M. , Amanullah, F., Dharmadhikari, A., Nardell, E.A., Seddon, J.A., Vasilyeva, I., et al. (2015) Turning off the Tap: Stopping Tuberculosis Transmission through Active Case-Finding and Prompt Effective Treatment. Lancet, 386, 2334-2343. [CrossRef]
- Federal Ministry of Health (2019). National TB and leprosy control program annual report 2019. https://www.health.gov.ng/doc/Draft-2019-NTBLCP-Annual-report-22032020.pdf.
- Onuka, O. , Okezie, I., Ahukanna, J., Okebaram, C., Dakum, P., Agbaje, A., Ibeziako, V., Mustapha, G., Chukwueme, N., Ubochioma, E., Okorie, A., Charles, N. and Anago, C. (2018) Effectiveness of Contact Tracing of Index Tuberculosis Cases in Nigeria. Advances in Infectious Diseases, 8, 173-199. [CrossRef]
- Azuogu, B. N. , Ogbonnaya, L. U., & Obumneme-Anyim, N. (2019). Contact tracing as a strategy for tuberculosis control in Nigeria: A review. International Journal of Mycobacteriology, 8(1), 1-7.
- Oshi, D. C. , Oshi, S. N., Alobu, I., & Ukwaja, K. N. (2017). Profile and determinants of treatment failure among smear-positive tuberculosis patients in Ebonyi, Nigeria. African Health Sciences, 17(3), 698-706. [CrossRef]
- Adejumo, O. A. , Daniel, O. J., & Otesanya, A. F. (2016). Community involvement in tuberculosis control in Lagos, Nigeria: why does it work in some areas and not in others? Transactions of the Royal Society of Tropical Medicine and Hygiene, 110(2), 75-81.
- Lawson, L., Muc, M., Oladimeji, O., Iweha, C., Opoola, B., Abdurhaman, S., Bimba, J.S., & Cuevas, L.E. (2017). Tuberculosis and diabetes in Nigerian patients with and without HIV. International Journal of Infectious Diseases, 61, 121-125. [CrossRef]
- Shamanewadi, A. N. , Naik, P. R., Thekkur, P., Madhukumar, S., Nirgude, A. S., Pavithra, M. B., Poojar, B., Sharma, V., Urs, A. P., Nisarga, B. V., Shakila, N., & Nagaraja, S. B. (2020). Enablers and Challenges in the Implementation of Active Case Findings in a Selected District of Karnataka, South India: A Qualitative Study. Tuberculosis research and treatment, 2020, 9746329. [CrossRef]
- Aiyegoro, O. A. (2016). Determinants of adherence to tuberculosis therapy among patients receiving directly observed treatment from a district hospital in Pretoria, South Africa.
- Humayun, M. , Chirenda, J., Ye, W., Mukeredzi, I., Mujuru, H. A., & Yang, Z. (2022). Effect of Gender on Clinical Presentation of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection. Open forum infectious diseases, 9(10), ofac512. [CrossRef]
- Horton KC, MacPherson P, Houben RMGJ, White RG, Corbett EL, 2016. Sex differences in tuberculosis burden and notifications in low- and middle-income countries: a systematic review and meta-analysis. PLoS Med 2016; 13:e1002119. [CrossRef]
- Nhamoyebonde S, Leslie A. Biological differences between the sexes and susceptibility to tuberculosis. J Infect Dis 2014; 209:S100–6. [CrossRef]
- Khatri, G.R. & Frieden, T.R. (2000). The status and prospects of tuberculosis control in India. The International Journal of Tuberculosis and Lung Disease; 4(3):193-200.
- Chakraborty, A.K. (2004). Epidemiology of Tuberculosis: Current Status in India. The Indian Journal of Medical Research; 120, 248-276.
- Chan-Yeung, M. , Tam, C.M., Wong, H., Leung, C.C., Wang, J., Yew, W.W., Lam, C.W. & Kam, K.M. (2003). Molecular and conventional epidemiology of tuberculosis in Hong Kong: a population based prospective study. Journal of Clinical Microbiology; 41: 2706-2708. [CrossRef]
- Bam, D.S. , Gunneberg, C., Jha, K.K., Malla, P., Pant, R.P. & Bam, T.S. (2006). Success story of tuberculosis control in Nepal. SAARC Journal of Tuberculosis, Lung Diseases & HIV/AIDS; 1, 43–48.
- O'Boyle, S.J., Power, J.J., Ibrahim, M.Y. & Watson, J.P. (2002). Factors affecting patient compliance with anti-tuberculosis chemotherapy using the directly observed treatment, short course strategy (DOTS). The International Journal of Tuberculosis and Lung Disease; 6(4):307-12.
- Pushpananthan, S. , Walley, J.A. & Wright, J. (2000). Tuberculosis in Swaziland: a health needs assessment in preparation for a community-based programme. Tropical Doctor; 30 (4): 216-204(277). [CrossRef]
- Gebremariam, M.K. Bjune, G.A. & Frich, J.C. (2011). Lay beliefs of TB and TB/HIV coinfection in Addis Ababa, Ethiopia: A qualitative study. BioMed Central Research Notes;
- Maswanganyi, N.V. , Lebese, R.T., Mashau, N.S. & Khoza, L.B. (2014). 'Patient-perceived factors contributing to low tuberculosis cure rate at Greater Giyani healthcare facilities', Health SA Gesondheid 19(1), Art. #724, 8 pages. [CrossRef]
- Iweama, C. N. , Agbaje, O. S., Umoke, P. C. I., Igbokwe, C. C., Ozoemena, E. L., Omaka-Amari, N. L., & Idache, B. M. (2021). Nonadherence to tuberculosis treatment and associated factors among patients using directly observed treatment short-course in north-west Nigeria: A cross-sectional study. SAGE open medicine, 9, 2050312121989497. [CrossRef]
- Amiya A. Ahmed, Megan Grammatico, Anthony P. Moll, Sipho Malinga, Philile Makhunga, Salome Charalambous, Joseph B. Ladines-Lim, Justin Jones, Koeun Choi & Sheela V. Shenoi (2021) Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa, Global Health Action, 14:1, 1979281. [CrossRef]
- Teklay G, Teklu T, Legesse B, et al. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study. BMC Public Health. 2016;16:840. PubMed PubMed Central PMCID: PMC4992328. [PubMed]
- Yunusa F, Bello M, Kayode GA, et al. Uptake of tuberculosis prevention therapy in people living with HIV/AIDS in northern Nigeria: a programme to increase use of isoniazid preventive therapy. Lancet Glob Health. 2020;8:S37. [CrossRef]
- Reddy MM, Thekkur P, Ramya N, et al. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India. Glob Health Action. 2020;13:1704540. PubMed PubMed Central PMCID: PMC7006687. [PubMed]
- World Health Organization. Global Tuberculosis Report 2017: Leave no one behind - Unite to end TB. (2017). Available from http://www.who.int/tb/publications/global_report/gtbr2017_main_text.pdf?ua=1.
- World Health Organization (2020). Global tuberculosis report 2020. Geneva: World Health Organization; 2020. Licence: CC BY-NC-SA 3.0 IGO. Available from https://www.who.int/publications/i/item/9789240013131.
- Federal Ministry of Health. (2022). Standard Operating Procedure for Contact Investigation and Tuberculosis Preventive Treatment. National Tuberculosis, Leprosy and Buruli Ulcer Control Programme. Available at https://ntblcp.org.ng/content/uploads/2023/06/FINAL-SOP-CONTACT-INVESTIGATION-AND-TPT_JAN-2021-1.
- Morrison, J. , Pai, M., Hopewell, PC. (2008) Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis, (8) 359–68. [CrossRef]
- World Health Organization. (2012) Recommendations for investigating contacts of persons with infectious tuberculosis in low and middle-income countries. http://www.who.int/tb/publications/2012/contact_investigation2012/en/.
- Macq J, Solis A, Martinez G. Assessing the stigma of tuberculosis. Psychology, Health & Medicine. 2006;11(3):346–352. [CrossRef]
- Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J. Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res. 2009;9:169. PubMed Epub 2009/09/22. [CrossRef]
- Sulis G, Roggi A, Matteelli A, Raviglione MC. Tuberculosis: epidemiology and control. Mediterranean Journal of Hematology and Infectious Diseases. 2014;6(1):e2014070. Epub 2014/11/20. [CrossRef]
- The Union, author. Tackling TB Stigma - a necessary step towards humanising TB, viewed. 2017. 25 Jul. 20, https://www.theunion.org/news-centre/news/tackling-tb-stigma-humanising-tb.
- Christodoulou, M. The stigma of tuberculosis. The Lancet Infectious Diseases. 2011;11(9):663–664. [CrossRef]
- Baral SC, Karki DK, Newell JN. Causes of stigma and discrimination associated with tuberculosis in Nepal: a qualitative study. BMC Public Health. 2007;7:211. [CrossRef]
- Cremers AL, de Laat MM, Kapata N, Gerrets R, Klipstein-Grobusch K, Grobusch MP. Assessing the Consequences of Stigma for Tuberculosis Patients in Urban Zambia. PLoS One. 2015;10(3):e0119861. [CrossRef]
- TB Alert. Stigma and myths. 2018. Oct 24, Available from: https://www.tbalert.org/about-tb/global-tb-challenges/stigma-myths/.
- Ngamvithayapong J, Winkvist A, Diwan V. High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand. AIDS (London, England) 2000;14(10):1413–1419.
- Coreil J, Mayard G, Simpson KM, Lauzardo M, Zhu Y, Weiss M. Structural forces and the production of TB-related stigma among Haitians in two contexts. Soc Sci Med. 2010;71(8):1409–1417. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
